Glutamate-based Therapies for Psychiatric Disorders

Nonfiction, Health & Well Being, Psychology, Psychiatry, Medical, Medical Science, Pharmacology
Cover of the book Glutamate-based Therapies for Psychiatric Disorders by , Birkhäuser Basel
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783034602419
Publisher: Birkhäuser Basel Publication: September 7, 2010
Imprint: Birkhäuser Language: English
Author:
ISBN: 9783034602419
Publisher: Birkhäuser Basel
Publication: September 7, 2010
Imprint: Birkhäuser
Language: English

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Both metabotropic and ionotropic glutamate receptors present attractive “druggable” targets in treating disorders of the central nervous system. There has been a dramatic shift in the focus of glutamate-based therapies away from neurologic disorders such as stroke and traumatic brain injury to the treatment of psychiatric disorders. This “Milestones in Drug Therapy” volume offers a unique, contemporary overview of preclinical and clinical evidence that modulating glutamatergic tone is an effective means of treating psychiatric disorders ranging from depression and anxiety to schizophrenia and drug abuse. The ability to treat diseases such as depression and schizophrenia through multiple, glutamate-based mechanisms offers a unique therapeutic opportunity, as described in this book.

More books from Birkhäuser Basel

Cover of the book Vitamin A and Retinoids: An Update of Biological Aspects and Clinical Applications by
Cover of the book Autoimmune Aspects of Lung Disease by
Cover of the book Immunology and Drug Therapy of Allergic Skin Diseases by
Cover of the book Recent Advances in the Pathophysiology of COPD by
Cover of the book Information and Creation by
Cover of the book Modern Immunosuppressives by
Cover of the book Inflammatory Processes: by
Cover of the book Metalloproteinases as Targets for Anti-Inflammatory Drugs by
Cover of the book Medicinal Fatty Acids in Inflammation by
Cover of the book Nitric Oxide in Pulmonary Processes by
Cover of the book Inducible Enzymes in the Inflammatory Response by
Cover of the book Landslide Tsunamis: Recent Findings and Research Directions by
Cover of the book Computer Analysis of Scenes of 3-Dimensional Curved Objects by
Cover of the book Subduction Zones Part II by
Cover of the book Monitoring the Comprehensive Nuclear-Test-Ban-Treaty: Hydroacoustics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy